Showing 741-750 of 10108 results for "".
Evaluation of Cosmetic Training in Dermatology Residency
https://practicaldermatology.com/youngmd-connect/resident-resource-center/evaluation-of-cosmetic-training-in-dermatology-residency/23670/Survey findings highlight the need to expand cosmetic training in US residency programs.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitI Invested in One Laser When I Opened My Practice and This is How It Turned Out
https://practicaldermatology.com/topics/general-topics/i-invested-in-one-laser-when-i-opened-my-practice-and-this-is-how-it-turned-out/20017/Medical dermatology is a tough field to scale with numerous competitors in the market but Dr. Joyce Imahiyerobo-Ip found ways to compete. She shares the struggles of starting a new practice and the difficulties of selling aesthetic services as a dermatologist. A key to her success was the Aerolase N6-Plus Ways to Promote New Devices, Innovative Treatments
https://practicaldermatology.com/topics/practice-management/6-plus-ways-to-promote-new-devices-innovative-treatments/23587/There are many ways to use digital tools like email, social media, and video to promote your services.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.SARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Seeing the Individual in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/seeing-the-individual-in-ad-care/19890/The best care for patients with atopic dermatitis requires a holistic approach, suggests Dr. Stephan Weidinger. He discusses strategies to improve the management of this complex diseases and highlights innovative strategies for care identified through the Quality of Care in Atopic Dermatitis initiatTry New Things
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/try-new-things/19690/For the field of aesthetics to move forward, innovation is essential. Brian Biesman, MD discusses a responsible approach to trying new things in the clinical setting and stresses the need for caution at times.Advances in Skin Cancer Detection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-skin-cancer-detection/19685/Early detection is the best defense against skin cancers, and new technologies are assisting in the fight, says Anthony Rossi, MD. He highlights new and emerging advancements.